Table 1 Pre-treatment characteristics of participants
Characteristics | Experimental group (n = 20) | Control group (n = 20) |
|---|---|---|
Age (yr), mean (SD) | 8.12 (0.88) | 7.85 (1.06) |
Weight (kg), mean (SD) | 29.15 (2.13) | 28.5 (2.18) |
Height (m), mean (SD) | 1.30 (2.28) | 1.29 (2.20) |
Gender | ||
 n male (%) | 12 (60%) | 9 (45%) |
 n female (%) | 8 (40%) | 11 (55%) |
MAS, n (%) | ||
 1 | 7 (35%) | 5 (25%) |
 1+ | 8 (40%) | 9 (45%) |
 2 | 5 (25%) | 6 (30%) |
GMFCS, n (%) | ||
 I | 11 (55%) | 8 (40%) |
 II | 9 (45%) | 12 (60%) |